Children's Acetaminophen Oral Suspension, 650 mg/20.3 mL unit dose cup (NDC 68094-650-59), packag...

FDA Drug Recall #D-250-2013 — Class II — March 21, 2013

Recall Summary

Recall Number D-250-2013
Classification Class II — Moderate risk
Date Initiated March 21, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Precision Dose Inc.
Location South Beloit, IL
Product Type Drugs
Quantity 9,268 cases

Product Description

Children's Acetaminophen Oral Suspension, 650 mg/20.3 mL unit dose cup (NDC 68094-650-59), packaged in 30-count cups per shipper case (NDC 68094-650-62), Pkg. By: Precision Dose, Inc., S. Beloit, IL 61080.

Reason for Recall

Labeling: Not Elsewhere Classified: This unit dose product is being recalled because the product's name includes the word "Children's" which is misleading since the 650 mg dose of acetaminophen contained within it, is an adult dose.

Distribution Pattern

Nationwide and Puerto Rico

Lot / Code Information

Lot #: 101456, Exp 05/13; 101488, Exp 06/13: 101499, 101503, Exp 07/13; 101537, 101552, 101554, Exp 08/13; 101611, 101616, 101623, Exp 10/13; 101630, Exp 11/13; 101754, Exp 03/14

Other Recalls from Precision Dose Inc.

Recall # Classification Product Date
D-0095-2022 Class II Acetaminophen Oral Suspension, 325 mg/10.15 mL,... Nov 1, 2021
D-0094-2022 Class II Acetaminophen Oral Suspension, 160 mg/5 mL, pac... Nov 1, 2021
D-0228-2021 Class II Chlorhexidine Gluconate Oral Rinse USP 0.12%, p... Jan 1, 2021
D-1004-2020 Class II Ranitidine Oral Solution, USP, 150 mg/10 mL, [1... Nov 13, 2019
D-0057-2018 Class III Carbamazepine Oral Suspension USP, 100 mg/5 mL,... Sep 25, 2017

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.